Business Description
NRGene Technologies Ltd
ISIN : IL0011720716
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.09 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -0.18 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -3.97 | |||||
Beneish M-Score | -3.74 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -34.7 | |||||
3-Year EBITDA Growth Rate | -36.5 | |||||
3-Year EPS without NRI Growth Rate | -14.3 | |||||
3-Year FCF Growth Rate | -55.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.22 | |||||
9-Day RSI | 62.2 | |||||
14-Day RSI | 63.91 | |||||
6-1 Month Momentum % | 103.86 | |||||
12-1 Month Momentum % | 5.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.48 | |||||
Quick Ratio | 2.48 | |||||
Cash Ratio | 2.22 | |||||
Days Sales Outstanding | 56.06 | |||||
Days Payable | 97.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 2.92 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 45.02 | |||||
Operating Margin % | -263.89 | |||||
Net Margin % | -262.02 | |||||
FCF Margin % | -278.61 | |||||
ROE % | -53.78 | |||||
ROA % | -37.62 | |||||
ROIC % | -107.79 | |||||
ROC (Joel Greenblatt) % | -439.87 | |||||
ROCE % | -48.44 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 9.67 | |||||
PB Ratio | 2.7 | |||||
Price-to-Tangible-Book | 3.93 | |||||
EV-to-EBIT | -2.48 | |||||
EV-to-EBITDA | -2.81 | |||||
EV-to-Revenue | 6.38 | |||||
EV-to-FCF | -2.65 | |||||
Price-to-Net-Current-Asset-Value | 5.36 | |||||
Price-to-Net-Cash | 6.75 | |||||
Earnings Yield (Greenblatt) % | -40.38 | |||||
FCF Yield % | -30.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
NRGene Technologies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 7.438 | ||
EPS (TTM) (₪) | -1.562 | ||
Beta | 0 | ||
Volatility % | 126.89 | ||
14-Day RSI | 63.91 | ||
14-Day ATR (₪) | 0.409808 | ||
20-Day SMA (₪) | 4.9722 | ||
12-1 Month Momentum % | 5.63 | ||
52-Week Range (₪) | 1.55 - 6.4 | ||
Shares Outstanding (Mil) | 12.6 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NRGene Technologies Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NRGene Technologies Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
NRGene Technologies Ltd Frequently Asked Questions
What is NRGene Technologies Ltd(XTAE:NRGN)'s stock price today?
When is next earnings date of NRGene Technologies Ltd(XTAE:NRGN)?
Does NRGene Technologies Ltd(XTAE:NRGN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |